NYSE : BIO.B

Bio-Rad Laboratories, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 379.5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Bio-Rad Laboratories, Inc. (BIO.B) reported revenue of 2.59B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.59B2.58B2.57B2.67B2.80B2.92B
Cost of Revenue1.24B1.24B1.17B1.24B1.23B1.26B
Gross Profit1.35B1.34B1.39B1.43B1.57B1.66B
Selling, General & Admin827.50M819.80M810.20M824.20M827.80M851.02M
Research & Development247.70M257.60M294.30M240.90M256.90M247.34M
Operating Expenses1.08B1.08B1.10B1.07B1.08B1.10B
Operating Income272.30M266.20M289.20M365.70M482.60M564.74M
Interest Expense-48.80M-49.00M-48.90M-49.40M-38.10M-1.55M
Interest & Investment Income87.90M95.50M82.00M100.90M58.10M18.90M
Currency Exchange Gain (Loss)7.60M6.60M3.90M7.30M200.00K-2.75M
Other Non Operating Income (Expenses)-200.00K-300.00K3.20M4.90M-5.20M675.00K
EBT Excluding Unusual Items318.80M319.00M329.40M429.40M497.60M580.01M
Merger & Restructuring Charges-46.10M-46.10M-21.80M-27.90M-64.40M
Gain (Loss) on Sale of Investments250.50M895.40M-2.65B-1.25B-5.20B4.93B
Gain (Loss) on Sale of Assets1.40M
Asset Writedown-172.80M-172.80M
Pretax Income350.40M995.50M-2.34B-850.10M-4.70B5.45B
Income Tax Expense128.00M235.60M-498.30M-212.80M-1.08B1.19B
Net Income222.40M759.90M-1.84B-637.30M-3.63B4.25B
Net Income to Common222.40M759.90M-1.84B-637.30M-3.63B4.25B
Shares Outstanding (Basic)26.92M27.28M28.21M29.21M29.79M29.83M
Shares Outstanding (Diluted)26.92M27.28M28.21M29.21M29.79M30.21M
EPS (Basic)8.2627.85-65.36-21.82-121.79142.61
EPS (Diluted)8.2627.85-65.36-21.82-121.79140.83
Free Cash Flow353.10M374.60M289.60M218.20M81.60M535.75M
Free Cash Flow Per Share13.1213.7310.267.472.7417.74
Gross Margin52.04%52.01%54.30%53.56%55.93%56.91%
Operating Margin10.52%10.30%11.27%13.69%17.22%19.32%
Profit Margin8.59%29.42%-71.86%-23.86%-129.45%145.57%
Free Cash Flow Margin13.64%14.50%11.28%8.17%2.91%18.33%
EBITDA441.00M431.60M440.80M511.60M619.90M702.34M
EBITDA Margin17.03%16.71%17.18%19.15%22.12%24.03%
D&A For EBITDA168.70M165.40M151.60M145.90M137.30M137.60M
EBIT272.30M266.20M289.20M365.70M482.60M564.74M
EBIT Margin10.52%10.30%11.27%13.69%17.22%19.32%
Effective Tax Rate36.53%23.67%21.93%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents517.00M529.80M488.10M403.80M434.21M470.78M
Short-Term Investments1.10B1.01B1.18B1.20B1.36B399.13M
Cash & Short-Term Investments1.62B1.54B1.66B1.61B1.79B869.92M
Accounts Receivable441.80M460.60M452.50M489.00M494.64M423.54M
Other Receivables8.90M11.90M13.10M11.90M11.60M2.20M
Receivables450.70M472.50M465.60M500.90M506.25M425.74M
Inventory780.60M740.70M760.00M780.50M719.32M572.24M
Prepaid Expenses147.80M136.50M122.60M140.00M124.18M109.14M
Restricted Cash1.60M2.00M1.40M200.00K13.00K14.00K
Other Current Assets21.30M13.80M16.20M19.60M17.55M13.44M
Total Current Assets3.02B2.91B3.03B3.05B3.16B1.99B
Property, Plant & Equipment671.90M709.90M688.60M723.70M679.56M716.44M
Long-Term Investments5.72B6.10B4.84B7.70B8.83B14.39B
Goodwill574.30M579.80M410.50M413.60M406.49M347.34M
Other Intangible Assets160.00M174.30M293.60M320.50M332.15M253.94M
Other Long-Term Assets102.70M103.80M103.50M96.40M95.80M105.49M
Total Assets10.25B10.58B9.36B12.30B13.50B17.80B
Accounts Payable143.50M129.00M122.30M144.60M135.04M141.94M
Accrued Expenses150.50M172.30M124.20M139.90M194.79M312.97M
Current Portion of Long-Term Debt400.20M800.00K800.00K
Current Portion of Leases34.10M36.60M42.10M40.90M36.80M36.92M
Current Income Taxes Payable74.20M36.60M31.20M35.80M32.43M10.32M
Current Unearned Revenue52.50M48.90M47.80M50.85M
Other Current Liabilities106.30M92.80M99.40M161.60M169.65M127.94M
Total Current Liabilities961.30M517.00M467.80M522.80M568.71M680.94M
Long-Term Debt794.60M1.19B1.19B1.19B1.19B3.00K
Long-Term Leases141.50M154.40M140.60M175.10M163.73M186.45M
Long-Term Unearned Revenue13.50M14.00M13.70M
Pension & Post-Retirement Benefits49.20M56.90M59.50M45.30M73.80M
Long-Term Deferred Tax Liabilities982.20M1.06B818.00M1.48B1.77B3.06B
Other Long-Term Liabilities185.00M135.90M106.60M135.50M150.61M108.39M
Total Liabilities3.08B3.12B2.79B3.56B3.89B4.11B
Common Stock3.00K3.00K
Additional Paid-In Capital502.90M476.00M463.20M449.10M447.45M441.73M
Retained Earnings8.02B8.18B7.42B9.26B9.90B13.53B
Treasury Stock-1.08B-1.01B-772.10M-632.50M-263.59M-106.29M
Comprehensive Income & Other-271.30M-189.10M-538.20M-336.00M-466.82M-175.55M
Shareholders' Equity7.17B7.45B6.57B8.74B9.62B13.69B
Total Liabilities & Equity10.25B10.58B9.36B12.30B13.50B17.80B
Total Debt1.37B1.38B1.37B1.41B1.39B223.38M
Net Cash (Debt)248.10M155.90M289.80M201.60M402.56M646.54M
Net Cash Per Share9.225.7110.276.9013.5221.40
Filing Date Shares Outstanding26.74M26.99M28.01M28.52M29.60M29.93M
Total Common Shares Outstanding26.74M26.99M28.01M28.52M29.60M29.93M
Working Capital2.06B2.39B2.56B2.53B2.59B1.31B
Book Value Per Share268.30276.16234.52306.51324.89457.20
Tangible Book Value6.44B6.70B5.87B8.01B8.88B13.08B
Tangible Book Value Per Share240.84248.22209.39280.77299.93437.12
Land28.90M27.80M28.40M27.80M27.94M
Buildings449.40M426.30M419.80M393.60M385.80M
Machinery1.32B1.18B1.15B1.09B1.10B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income222.40M759.90M-1.84B-637.30M-3.63B4.25B
Depreciation & Amortization168.70M165.40M151.60M145.90M137.30M137.60M
Loss (Gain) From Sale of Assets-2.50M-1.40M
Asset Writedown & Restructuring Costs172.80M172.80M29.50M
Loss (Gain) From Sale of Investments-248.00M-894.40M2.66B1.25B5.21B-4.93B
Stock-Based Compensation60.30M58.00M62.30M61.30M60.90M51.20M
Other Operating Activities-6.60M-3.30M20.00M-12.00M22.10M8.74M
Change in Accounts Receivable21.30M19.60M16.20M11.40M-87.40M-20.40M
Change in Inventory27.50M68.90M8.50M-46.30M-158.80M46.10M
Change in Accounts Payable-8.50M-100.00K-40.90M-51.80M-94.20M69.90M
Change in Income Taxes51.70M1.50M24.10M-21.30M-1.20M-28.80M
Change in Other Net Operating Assets-15.00M12.00M-1.90M-2.20M-26.80M-8.60M
Operating Cash Flow492.60M532.20M455.20M374.90M194.40M669.50M
Capital Expenditures-139.50M-157.60M-165.60M-156.70M-112.80M-133.75M
Sale of Property, Plant & Equipment100.00K100.00K200.00K200.00K52.00K
Cash Acquisitions-700.00K-218.50M-100.70M-125.52M
Divestitures2.50M1.40M
Sale (Purchase) of Intangibles-23.40M-1.50M
Investment in Securities-96.90M186.30M28.70M174.20M-994.20M-84.73M
Investing Cash Flow-237.10M-189.70M-160.20M20.20M-1.21B-797.38M
Long-Term Debt Issued1.19B
Long-Term Debt Repaid-500.00K-400.00K-500.00K-500.00K-3.02M
Net Debt Issued (Repaid)-500.00K-500.00K-400.00K-500.00K1.19B-3.02M
Issuance of Common Stock14.90M15.80M19.20M18.50M17.60M20.63M
Repurchase of Common Stock-135.70M-298.50M-207.00M-443.60M-229.70M-72.48M
Other Financing Activities500.00K-30.60M-561.00K
Financing Cash Flow-120.80M-283.20M-218.80M-425.60M973.60M-55.43M
Foreign Exchange Rate Adjustments12.40M-16.90M9.20M400.00K3.00M-12.64M
Miscellaneous Cash Flow Adjustments-36.00K
Net Cash Flow147.10M42.40M85.40M-30.10M-36.60M-195.98M
Free Cash Flow353.10M374.60M289.60M218.20M81.60M535.75M
Free Cash Flow Margin13.64%14.50%11.28%8.17%2.91%18.33%
Free Cash Flow Per Share13.1213.7310.267.472.7417.74
Levered Free Cash Flow283.19M256.55M193.49M124.28M2.86M485.98M
Unlevered Free Cash Flow313.69M287.18M224.05M155.16M26.68M486.95M
Cash Income Tax Paid29.80M61.60M99.40M129.60M158.30M134.68M
Change in Working Capital121.60M272.40M-620.80M-432.80M-1.61B1.14B

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization9.99B8.21B9.18B9.40B12.46B22.44B
Enterprise Value9.74B8.19B8.95B9.05B11.99B21.33B
Last Close Price379.50310.70325.60320.65404.66722.91
PE Ratio45.9710.815.28
PS Ratio3.863.183.583.524.457.68
PB Ratio1.391.101.401.071.301.64
P/TBV Ratio1.551.231.571.171.401.72
P/FCF Ratio28.2921.9231.7143.08152.7041.88
P/OCF Ratio20.2815.4320.1725.0764.1033.52
EV/Sales Ratio3.763.173.493.394.287.30
EV/EBITDA Ratio22.0918.9720.3017.6819.3430.37
EV/EBIT Ratio35.7730.7630.9424.7424.8437.77
EV/FCF Ratio27.5921.8630.9041.46146.9339.81
Debt / Equity Ratio0.190.190.210.160.140.02
Debt / EBITDA Ratio2.692.782.692.442.050.30
Debt / FCF Ratio3.883.704.756.4417.010.42
Net Debt / Equity Ratio-0.04-0.02-0.04-0.02-0.04-0.05
Net Debt / EBITDA Ratio-0.56-0.36-0.66-0.39-0.65-0.92
Net Debt / FCF Ratio-0.70-0.42-1.00-0.92-4.93-1.21
Asset Turnover0.250.260.240.210.180.19
Inventory Turnover1.571.651.521.651.912.11
Quick Ratio2.153.894.554.034.041.90
Current Ratio3.145.626.485.835.552.92
Return on Equity (ROE)3.11%10.84%-24.09%-6.94%-31.14%36.11%
Return on Assets (ROA)1.66%1.67%1.67%1.77%1.93%2.29%
Return on Invested Capital (ROIC)2.54%2.99%3.90%4.12%4.34%3.98%
Return on Capital Employed (ROCE)2.90%2.60%3.30%3.10%3.70%3.30%
Earnings Yield2.18%9.25%-20.08%-6.78%-29.11%18.96%
FCF Yield3.54%4.56%3.15%2.32%0.66%2.39%
Buyback Yield / Dilution3.11%3.31%3.41%1.93%1.40%-0.16%